

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.13900932 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.13900932 |
| 3 | hemidesmosome assembly (GO:0031581) | 4.06016919 |
| 4 | protein retention in ER lumen (GO:0006621) | 4.04574739 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 3.85007268 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 3.85007268 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 3.70077421 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.70077421 |
| 9 | skin morphogenesis (GO:0043589) | 3.64658936 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 3.50704403 |
| 11 | desmosome organization (GO:0002934) | 3.44527417 |
| 12 | protein hydroxylation (GO:0018126) | 3.27757863 |
| 13 | protein carboxylation (GO:0018214) | 3.26286029 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.26286029 |
| 15 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.25142033 |
| 16 | protein localization to endosome (GO:0036010) | 3.16715072 |
| 17 | peptidyl-proline hydroxylation (GO:0019511) | 3.13704460 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 3.10240085 |
| 19 | cysteine metabolic process (GO:0006534) | 3.09387137 |
| 20 | iron ion import (GO:0097286) | 3.09353713 |
| 21 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.08579784 |
| 22 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.03715804 |
| 23 | collagen fibril organization (GO:0030199) | 3.02226937 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 3.02214911 |
| 25 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.02142911 |
| 26 | myelin maintenance (GO:0043217) | 2.95636093 |
| 27 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.90611186 |
| 28 | paraxial mesoderm development (GO:0048339) | 2.89549608 |
| 29 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.88495043 |
| 30 | homocysteine metabolic process (GO:0050667) | 2.87553207 |
| 31 | bile acid biosynthetic process (GO:0006699) | 2.86618790 |
| 32 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.86172492 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 2.79915239 |
| 34 | drug transmembrane transport (GO:0006855) | 2.79704075 |
| 35 | wound healing, spreading of epidermal cells (GO:0035313) | 2.79698292 |
| 36 | chondrocyte proliferation (GO:0035988) | 2.79204255 |
| 37 | endodermal cell differentiation (GO:0035987) | 2.79143073 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 2.79007334 |
| 39 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.77403221 |
| 40 | membrane budding (GO:0006900) | 2.76653483 |
| 41 | complement activation, alternative pathway (GO:0006957) | 2.75885595 |
| 42 | cell adhesion mediated by integrin (GO:0033627) | 2.75873806 |
| 43 | glyoxylate metabolic process (GO:0046487) | 2.75212718 |
| 44 | nuclear pore complex assembly (GO:0051292) | 2.74016732 |
| 45 | COPII vesicle coating (GO:0048208) | 2.73669262 |
| 46 | response to lipoprotein particle (GO:0055094) | 2.72965359 |
| 47 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.71903219 |
| 48 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.71228317 |
| 49 | negative regulation of anoikis (GO:2000811) | 2.71068505 |
| 50 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.70702048 |
| 51 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.70408944 |
| 52 | mesodermal cell differentiation (GO:0048333) | 2.70261516 |
| 53 | 4-hydroxyproline metabolic process (GO:0019471) | 2.69024556 |
| 54 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.66735128 |
| 55 | bile acid metabolic process (GO:0008206) | 2.66240162 |
| 56 | negative regulation of protein activation cascade (GO:2000258) | 2.64684380 |
| 57 | intestinal cholesterol absorption (GO:0030299) | 2.64225340 |
| 58 | cellular zinc ion homeostasis (GO:0006882) | 2.64143047 |
| 59 | regulation of fibrinolysis (GO:0051917) | 2.62975086 |
| 60 | low-density lipoprotein particle clearance (GO:0034383) | 2.61761249 |
| 61 | fatty acid elongation (GO:0030497) | 2.61341412 |
| 62 | reverse cholesterol transport (GO:0043691) | 2.60943249 |
| 63 | membrane protein ectodomain proteolysis (GO:0006509) | 2.60692559 |
| 64 | negative regulation of complement activation (GO:0045916) | 2.60374120 |
| 65 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.58866891 |
| 66 | regulation of plasminogen activation (GO:0010755) | 2.58657366 |
| 67 | regulation of protein activation cascade (GO:2000257) | 2.58416998 |
| 68 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.57619929 |
| 69 | peptidyl-asparagine modification (GO:0018196) | 2.56311711 |
| 70 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.56307752 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 2.55539795 |
| 72 | apoptotic cell clearance (GO:0043277) | 2.55269528 |
| 73 | cell-substrate junction assembly (GO:0007044) | 2.53738047 |
| 74 | substrate-dependent cell migration (GO:0006929) | 2.53534248 |
| 75 | regulation of cholesterol homeostasis (GO:2000188) | 2.53503634 |
| 76 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.53438800 |
| 77 | cholesterol efflux (GO:0033344) | 2.53196766 |
| 78 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52214552 |
| 79 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.52005732 |
| 80 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.51964729 |
| 81 | very long-chain fatty acid metabolic process (GO:0000038) | 2.50684408 |
| 82 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.50571371 |
| 83 | urea metabolic process (GO:0019627) | 2.49494527 |
| 84 | urea cycle (GO:0000050) | 2.49494527 |
| 85 | regulation of transforming growth factor beta production (GO:0071634) | 2.49304456 |
| 86 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49078558 |
| 87 | protein N-linked glycosylation (GO:0006487) | 2.47558553 |
| 88 | tyrosine metabolic process (GO:0006570) | 2.46845769 |
| 89 | regulation of complement activation (GO:0030449) | 2.45120583 |
| 90 | chondrocyte development (GO:0002063) | 2.44657492 |
| 91 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.44208263 |
| 92 | positive regulation of nuclease activity (GO:0032075) | 2.44055945 |
| 93 | hippo signaling (GO:0035329) | 2.43712271 |
| 94 | short-chain fatty acid metabolic process (GO:0046459) | 2.42716217 |
| 95 | central nervous system myelination (GO:0022010) | 2.42614261 |
| 96 | axon ensheathment in central nervous system (GO:0032291) | 2.42614261 |
| 97 | glutamate metabolic process (GO:0006536) | 2.42239197 |
| 98 | ER-nucleus signaling pathway (GO:0006984) | 2.41845730 |
| 99 | growth hormone receptor signaling pathway (GO:0060396) | 2.41714932 |
| 100 | positive regulation of glycolytic process (GO:0045821) | 2.41670793 |
| 101 | asymmetric protein localization (GO:0008105) | 2.40645985 |
| 102 | protein localization to cell surface (GO:0034394) | 2.40594691 |
| 103 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.40373824 |
| 104 | Golgi organization (GO:0007030) | 2.39784380 |
| 105 | regulation of lipoprotein metabolic process (GO:0050746) | 2.39416499 |
| 106 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.38819288 |
| 107 | response to methylmercury (GO:0051597) | 2.38545051 |
| 108 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.37994762 |
| 109 | intestinal absorption (GO:0050892) | 2.37967053 |
| 110 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.37782494 |
| 111 | gap junction assembly (GO:0016264) | 2.37770767 |
| 112 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.37080827 |
| 113 | sequestering of metal ion (GO:0051238) | 2.37004344 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 2.36851743 |
| 115 | nuclear pore organization (GO:0006999) | 2.36774127 |
| 116 | fibrinolysis (GO:0042730) | 2.35423713 |
| 117 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.35406717 |
| 118 | macroautophagy (GO:0016236) | 2.34699630 |
| 119 | lipoprotein metabolic process (GO:0042157) | 2.34450302 |
| 120 | endoplasmic reticulum organization (GO:0007029) | 2.34263362 |
| 121 | cellular response to unfolded protein (GO:0034620) | 2.34030785 |
| 122 | regulation of extracellular matrix disassembly (GO:0010715) | 2.33165316 |
| 123 | epithelial cell-cell adhesion (GO:0090136) | 2.31404353 |
| 124 | positive regulation of osteoblast proliferation (GO:0033690) | 2.31391901 |
| 125 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.31140689 |
| 126 | vesicle coating (GO:0006901) | 2.31108156 |
| 127 | cellular response to vitamin D (GO:0071305) | 2.31028117 |
| 128 | negative regulation of fatty acid transport (GO:2000192) | 2.30793790 |
| 129 | phospholipid homeostasis (GO:0055091) | 2.30237123 |
| 130 | protein-lipid complex assembly (GO:0065005) | 2.30035867 |
| 131 | smooth muscle tissue development (GO:0048745) | 2.29315001 |
| 132 | cellular copper ion homeostasis (GO:0006878) | 2.28681057 |
| 133 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.28565002 |
| 134 | triglyceride homeostasis (GO:0070328) | 2.28287530 |
| 135 | acylglycerol homeostasis (GO:0055090) | 2.28287530 |
| 136 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.28215778 |
| 137 | endocrine pancreas development (GO:0031018) | 2.27609148 |
| 138 | ER overload response (GO:0006983) | 2.26118794 |
| 139 | zinc ion transmembrane transport (GO:0071577) | 2.25951791 |
| 140 | acyl-CoA biosynthetic process (GO:0071616) | 2.25505305 |
| 141 | thioester biosynthetic process (GO:0035384) | 2.25505305 |
| 142 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.25337747 |
| 143 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.25168193 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.25081233 |
| 145 | virion attachment to host cell (GO:0019062) | 2.25081233 |
| 146 | lysine metabolic process (GO:0006553) | 2.24967727 |
| 147 | lysine catabolic process (GO:0006554) | 2.24967727 |
| 148 | midgut development (GO:0007494) | 2.24760547 |
| 149 | protein-lipid complex remodeling (GO:0034368) | 2.23757319 |
| 150 | macromolecular complex remodeling (GO:0034367) | 2.23757319 |
| 151 | plasma lipoprotein particle remodeling (GO:0034369) | 2.23757319 |
| 152 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.23704797 |
| 153 | kynurenine metabolic process (GO:0070189) | 2.23585430 |
| 154 | bile acid and bile salt transport (GO:0015721) | 2.23144779 |
| 155 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.22941491 |
| 156 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.22817847 |
| 157 | cholesterol transport (GO:0030301) | 2.22811823 |
| 158 | sterol transport (GO:0015918) | 2.22811823 |
| 159 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.22123944 |
| 160 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.22108491 |
| 161 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.21837495 |
| 162 | cellular response to vitamin (GO:0071295) | 2.21728444 |
| 163 | sterol homeostasis (GO:0055092) | 2.21551239 |
| 164 | localization within membrane (GO:0051668) | 2.21143603 |
| 165 | epoxygenase P450 pathway (GO:0019373) | 2.21035562 |
| 166 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.20999577 |
| 167 | zinc ion transport (GO:0006829) | 2.20363816 |
| 168 | lipid translocation (GO:0034204) | 2.20319664 |
| 169 | phospholipid translocation (GO:0045332) | 2.20319664 |
| 170 | embryonic process involved in female pregnancy (GO:0060136) | 2.19714554 |
| 171 | nitrogen cycle metabolic process (GO:0071941) | 2.19567117 |
| 172 | tryptophan metabolic process (GO:0006568) | 2.19253067 |
| 173 | keratan sulfate catabolic process (GO:0042340) | 2.19088745 |
| 174 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.19054619 |
| 175 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.18956424 |
| 176 | morphogenesis of an epithelial sheet (GO:0002011) | 2.17703284 |
| 177 | hypotonic response (GO:0006971) | 2.17272315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.30883860 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.26438349 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.23883543 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.10734523 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.90239184 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.88290725 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.71021502 |
| 8 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.62926440 |
| 9 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.47606077 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15279935 |
| 11 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.12560463 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.10160500 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03209413 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01768124 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.00846965 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.97896651 |
| 17 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.95264458 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87716815 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.84913319 |
| 20 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.84545629 |
| 21 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.84545629 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78119780 |
| 23 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.77790810 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76286592 |
| 25 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.73196099 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.72519900 |
| 27 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.69307604 |
| 28 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.68672003 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67410342 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66783938 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59764243 |
| 32 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.59660957 |
| 33 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.59232329 |
| 34 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.58869475 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.55537873 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54880570 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53693547 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48587755 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48377313 |
| 40 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.43805685 |
| 41 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.42788537 |
| 42 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.41895583 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41763937 |
| 44 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.39542361 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38134159 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35201747 |
| 47 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.34695848 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34083221 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.34056001 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33633735 |
| 51 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.31508443 |
| 52 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30848429 |
| 53 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.30563433 |
| 54 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29109870 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27170452 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26970402 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26818910 |
| 58 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22636001 |
| 59 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22067181 |
| 60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21174004 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19363448 |
| 62 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.18217744 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.17886030 |
| 64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.17817657 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17380731 |
| 66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13978549 |
| 67 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12165210 |
| 68 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11490632 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10691313 |
| 70 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.10676017 |
| 71 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10582971 |
| 72 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.09525232 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09352875 |
| 74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09152139 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07949121 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07511398 |
| 77 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.06807245 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05640813 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05483775 |
| 80 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05447913 |
| 81 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.05342079 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04738629 |
| 83 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04733769 |
| 84 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.04614322 |
| 85 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03434518 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03368070 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02859396 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02483314 |
| 89 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01228928 |
| 90 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.00674704 |
| 91 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00529732 |
| 92 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00477464 |
| 93 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.00402859 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99825396 |
| 95 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99414501 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99325363 |
| 97 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99276100 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99153154 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98923040 |
| 100 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.98704423 |
| 101 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98544012 |
| 102 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97426341 |
| 103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97219016 |
| 104 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96620237 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96592990 |
| 106 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96564959 |
| 107 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.96277936 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95399459 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94734678 |
| 110 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94720564 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93901017 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93893967 |
| 113 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93485575 |
| 114 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93476845 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93147438 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93042690 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92680286 |
| 118 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92322269 |
| 119 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92204598 |
| 120 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90799624 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90279705 |
| 122 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89765571 |
| 123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89172063 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88459593 |
| 125 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88375077 |
| 126 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88281610 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86643388 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86254671 |
| 129 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85878935 |
| 130 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.84454253 |
| 131 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82892483 |
| 132 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82240825 |
| 133 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81543239 |
| 134 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81543239 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80777958 |
| 136 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.78972780 |
| 137 | STAT3_23295773_ChIP-Seq_U87_Human | 0.78605982 |
| 138 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78525489 |
| 139 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.78351785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.22809899 |
| 2 | MP0005360_urolithiasis | 4.18183299 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.25914481 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.22371510 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.14035303 |
| 6 | MP0003300_gastrointestinal_ulcer | 3.13139644 |
| 7 | MP0005365_abnormal_bile_salt | 3.08679506 |
| 8 | MP0003252_abnormal_bile_duct | 3.00054028 |
| 9 | MP0003195_calcinosis | 2.93625422 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.84597886 |
| 11 | MP0003941_abnormal_skin_development | 2.78767796 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.43189203 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.26103286 |
| 14 | MP0010678_abnormal_skin_adnexa | 2.25587861 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.20572510 |
| 16 | MP0009384_cardiac_valve_regurgitation | 2.05639211 |
| 17 | MP0003690_abnormal_glial_cell | 1.97732227 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 1.96981886 |
| 19 | MP0000920_abnormal_myelination | 1.86321127 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.84416688 |
| 21 | MP0005083_abnormal_biliary_tract | 1.82278921 |
| 22 | MP0010329_abnormal_lipoprotein_level | 1.79247209 |
| 23 | MP0009840_abnormal_foam_cell | 1.76713756 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.75066189 |
| 25 | MP0004043_abnormal_pH_regulation | 1.69162523 |
| 26 | MP0004272_abnormal_basement_membrane | 1.68123617 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.67805659 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.62510117 |
| 29 | MP0005275_abnormal_skin_tensile | 1.60514292 |
| 30 | MP0000604_amyloidosis | 1.57920268 |
| 31 | MP0000383_abnormal_hair_follicle | 1.54251357 |
| 32 | MP0005023_abnormal_wound_healing | 1.49498055 |
| 33 | MP0006054_spinal_hemorrhage | 1.48532305 |
| 34 | MP0003868_abnormal_feces_composition | 1.46966380 |
| 35 | MP0002896_abnormal_bone_mineralization | 1.44804905 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.40635340 |
| 37 | MP0005332_abnormal_amino_acid | 1.38922543 |
| 38 | MP0005409_darkened_coat_color | 1.34195349 |
| 39 | MP0005220_abnormal_exocrine_pancreas | 1.29745742 |
| 40 | MP0003329_amyloid_beta_deposits | 1.28732986 |
| 41 | MP0003279_aneurysm | 1.27805283 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.27010387 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.26012397 |
| 44 | MP0000462_abnormal_digestive_system | 1.24812894 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.24656700 |
| 46 | MP0009697_abnormal_copulation | 1.24073147 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.23847809 |
| 48 | MP0001915_intracranial_hemorrhage | 1.21178522 |
| 49 | MP0005623_abnormal_meninges_morphology | 1.21098429 |
| 50 | MP0000762_abnormal_tongue_morphology | 1.19045715 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.18869736 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.18129402 |
| 53 | MP0000609_abnormal_liver_physiology | 1.14946912 |
| 54 | MP0003283_abnormal_digestive_organ | 1.13135998 |
| 55 | MP0001958_emphysema | 1.12601953 |
| 56 | MP0001299_abnormal_eye_distance/ | 1.10697620 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.08247715 |
| 58 | MP0002254_reproductive_system_inflammat | 1.07475895 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 1.04604805 |
| 60 | MP0000767_abnormal_smooth_muscle | 1.02754537 |
| 61 | MP0005408_hypopigmentation | 1.00453654 |
| 62 | MP0002060_abnormal_skin_morphology | 1.00229777 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 0.99706096 |
| 64 | MP0001944_abnormal_pancreas_morphology | 0.99699641 |
| 65 | MP0003075_altered_response_to | 0.98966122 |
| 66 | MP0004233_abnormal_muscle_weight | 0.97541669 |
| 67 | MP0003385_abnormal_body_wall | 0.96690231 |
| 68 | MP0003183_abnormal_peptide_metabolism | 0.94657121 |
| 69 | MP0000003_abnormal_adipose_tissue | 0.94276464 |
| 70 | MP0003091_abnormal_cell_migration | 0.93837920 |
| 71 | MP0002090_abnormal_vision | 0.93802951 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93469640 |
| 73 | MP0002009_preneoplasia | 0.93019209 |
| 74 | MP0004885_abnormal_endolymph | 0.92447729 |
| 75 | MP0003950_abnormal_plasma_membrane | 0.92274885 |
| 76 | MP0000537_abnormal_urethra_morphology | 0.91961217 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.91731218 |
| 78 | MP0005197_abnormal_uvea_morphology | 0.91639555 |
| 79 | MP0003634_abnormal_glial_cell | 0.90419406 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 0.88338381 |
| 81 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86338811 |
| 82 | MP0002909_abnormal_adrenal_gland | 0.86205149 |
| 83 | MP0003045_fibrosis | 0.85690722 |
| 84 | MP0005164_abnormal_response_to | 0.85227363 |
| 85 | MP0001243_abnormal_dermal_layer | 0.84578472 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.84032342 |
| 87 | MP0003303_peritoneal_inflammation | 0.83892020 |
| 88 | MP0005165_increased_susceptibility_to | 0.83873810 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.83598677 |
| 90 | MP0001542_abnormal_bone_strength | 0.82534119 |
| 91 | MP0002928_abnormal_bile_duct | 0.81899816 |
| 92 | MP0005451_abnormal_body_composition | 0.80989377 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 0.80654075 |
| 94 | MP0002078_abnormal_glucose_homeostasis | 0.79975175 |
| 95 | MP0004130_abnormal_muscle_cell | 0.79788363 |
| 96 | MP0005187_abnormal_penis_morphology | 0.79629488 |
| 97 | MP0005508_abnormal_skeleton_morphology | 0.79619707 |
| 98 | MP0001177_atelectasis | 0.79468943 |
| 99 | MP0000427_abnormal_hair_cycle | 0.79052838 |
| 100 | MP0001216_abnormal_epidermal_layer | 0.79037241 |
| 101 | MP0002269_muscular_atrophy | 0.78763860 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.77344478 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.76439427 |
| 104 | MP0000627_abnormal_mammary_gland | 0.75112464 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.74016528 |
| 106 | MP0005621_abnormal_cell_physiology | 0.73905828 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 0.73784699 |
| 108 | MP0009053_abnormal_anal_canal | 0.73028104 |
| 109 | MP0004947_skin_inflammation | 0.72724217 |
| 110 | MP0002168_other_aberrant_phenotype | 0.72657643 |
| 111 | MP0000534_abnormal_ureter_morphology | 0.72218026 |
| 112 | MP0002697_abnormal_eye_size | 0.71894726 |
| 113 | MP0000377_abnormal_hair_follicle | 0.71630834 |
| 114 | MP0001756_abnormal_urination | 0.71589027 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.71298148 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.71295353 |
| 117 | MP0000432_abnormal_head_morphology | 0.71229023 |
| 118 | MP0005248_abnormal_Harderian_gland | 0.70969513 |
| 119 | MP0003937_abnormal_limbs/digits/tail_de | 0.70587248 |
| 120 | MP0001849_ear_inflammation | 0.69927508 |
| 121 | MP0000428_abnormal_craniofacial_morphol | 0.69812764 |
| 122 | MP0004134_abnormal_chest_morphology | 0.69040072 |
| 123 | MP0002084_abnormal_developmental_patter | 0.67785815 |
| 124 | MP0000733_abnormal_muscle_development | 0.67486295 |
| 125 | MP0001661_extended_life_span | 0.67365192 |
| 126 | MP0002796_impaired_skin_barrier | 0.66868015 |
| 127 | MP0008004_abnormal_stomach_pH | 0.66731287 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.66485196 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.66437148 |
| 130 | MP0001879_abnormal_lymphatic_vessel | 0.66391282 |
| 131 | MP0005501_abnormal_skin_physiology | 0.66327367 |
| 132 | MP0002166_altered_tumor_susceptibility | 0.65662427 |
| 133 | MP0002998_abnormal_bone_remodeling | 0.65308600 |
| 134 | MP0005375_adipose_tissue_phenotype | 0.65174238 |
| 135 | MP0006082_CNS_inflammation | 0.64777457 |
| 136 | MP0005193_abnormal_anterior_eye | 0.64756859 |
| 137 | MP0002092_abnormal_eye_morphology | 0.63862343 |
| 138 | MP0001881_abnormal_mammary_gland | 0.63032505 |
| 139 | MP0005257_abnormal_intraocular_pressure | 0.62898755 |
| 140 | MP0003755_abnormal_palate_morphology | 0.61930419 |
| 141 | MP0004484_altered_response_of | 0.61696826 |
| 142 | MP0002098_abnormal_vibrissa_morphology | 0.61251831 |
| 143 | MP0000579_abnormal_nail_morphology | 0.61167937 |
| 144 | MP0005503_abnormal_tendon_morphology | 0.60366968 |
| 145 | MP0005636_abnormal_mineral_homeostasis | 0.60163058 |
| 146 | MP0000647_abnormal_sebaceous_gland | 0.60021111 |
| 147 | MP0010771_integument_phenotype | 0.59633966 |
| 148 | MP0003632_abnormal_nervous_system | 0.59365277 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.58942290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 4.37796714 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.19288328 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.94580250 |
| 4 | Xanthomatosis (HP:0000991) | 3.74204940 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.53008877 |
| 6 | Atrophic scars (HP:0001075) | 3.34911273 |
| 7 | Abnormality of the common coagulation pathway (HP:0010990) | 3.32628693 |
| 8 | Neurofibrillary tangles (HP:0002185) | 3.31895739 |
| 9 | Complement deficiency (HP:0004431) | 3.20693771 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.19694007 |
| 11 | Hypoglycemic seizures (HP:0002173) | 3.05264890 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 3.01436408 |
| 13 | Abnormality of the intrinsic pathway (HP:0010989) | 3.01089223 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.93718202 |
| 15 | Ketoacidosis (HP:0001993) | 2.88255695 |
| 16 | Epidermoid cyst (HP:0200040) | 2.87080891 |
| 17 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.84007807 |
| 18 | Papillary thyroid carcinoma (HP:0002895) | 2.80720239 |
| 19 | Ankle contracture (HP:0006466) | 2.76884647 |
| 20 | Tetraparesis (HP:0002273) | 2.76585888 |
| 21 | Dysostosis multiplex (HP:0000943) | 2.72728571 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 2.72704237 |
| 23 | Abnormality of dentin (HP:0010299) | 2.69380293 |
| 24 | Short nail (HP:0001799) | 2.68948673 |
| 25 | Ketosis (HP:0001946) | 2.65195488 |
| 26 | Prolonged partial thromboplastin time (HP:0003645) | 2.64580619 |
| 27 | Fat malabsorption (HP:0002630) | 2.64420857 |
| 28 | Right ventricular cardiomyopathy (HP:0011663) | 2.60441354 |
| 29 | Premature rupture of membranes (HP:0001788) | 2.59262324 |
| 30 | Cervical subluxation (HP:0003308) | 2.58861847 |
| 31 | Wormian bones (HP:0002645) | 2.57839366 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.57518924 |
| 33 | Mucopolysacchariduria (HP:0008155) | 2.57518924 |
| 34 | Vascular calcification (HP:0004934) | 2.49866133 |
| 35 | Vertebral compression fractures (HP:0002953) | 2.49081407 |
| 36 | Macroorchidism (HP:0000053) | 2.48459594 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 2.46756290 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 2.43620310 |
| 39 | Back pain (HP:0003418) | 2.43169456 |
| 40 | Skin nodule (HP:0200036) | 2.38192227 |
| 41 | Myocardial infarction (HP:0001658) | 2.36863886 |
| 42 | Termporal pattern (HP:0011008) | 2.36421426 |
| 43 | Insidious onset (HP:0003587) | 2.36421426 |
| 44 | Asymmetry of the thorax (HP:0001555) | 2.36140661 |
| 45 | Symptomatic seizures (HP:0011145) | 2.35575936 |
| 46 | Turricephaly (HP:0000262) | 2.35030897 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.34904751 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.33712529 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.33712529 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.33712529 |
| 51 | Follicular hyperkeratosis (HP:0007502) | 2.31957794 |
| 52 | Aortic aneurysm (HP:0004942) | 2.29624839 |
| 53 | Protuberant abdomen (HP:0001538) | 2.28417811 |
| 54 | Buphthalmos (HP:0000557) | 2.26028732 |
| 55 | Abnormality of complement system (HP:0005339) | 2.21023067 |
| 56 | Ankyloglossia (HP:0010296) | 2.20336499 |
| 57 | Soft skin (HP:0000977) | 2.19658866 |
| 58 | Thyroid carcinoma (HP:0002890) | 2.18428816 |
| 59 | Hematochezia (HP:0002573) | 2.18070408 |
| 60 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16700502 |
| 61 | Fragile skin (HP:0001030) | 2.16445185 |
| 62 | Joint hemorrhage (HP:0005261) | 2.16104445 |
| 63 | Pterygium (HP:0001059) | 2.15159029 |
| 64 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.14240250 |
| 65 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.14240250 |
| 66 | Spastic diplegia (HP:0001264) | 2.12885251 |
| 67 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.12553540 |
| 68 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.10423833 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.08963052 |
| 70 | Hepatocellular carcinoma (HP:0001402) | 2.08931504 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.07399924 |
| 72 | Intention tremor (HP:0002080) | 2.03861284 |
| 73 | Flat acetabular roof (HP:0003180) | 2.03591505 |
| 74 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03063483 |
| 75 | Abnormal delivery (HP:0001787) | 2.02966830 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 2.01623825 |
| 77 | Coronal craniosynostosis (HP:0004440) | 2.01122226 |
| 78 | Vertebral arch anomaly (HP:0008438) | 1.99530838 |
| 79 | Abdominal distention (HP:0003270) | 1.99513033 |
| 80 | Abnormality of carpal bone ossification (HP:0006257) | 1.99087320 |
| 81 | Increased CSF protein (HP:0002922) | 1.98417826 |
| 82 | Peritonitis (HP:0002586) | 1.97689733 |
| 83 | Epiphyseal dysplasia (HP:0002656) | 1.97202049 |
| 84 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.96911243 |
| 85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96457862 |
| 86 | Osteolytic defects of the hand bones (HP:0009699) | 1.96457862 |
| 87 | Pheochromocytoma (HP:0002666) | 1.96346470 |
| 88 | Subacute progressive viral hepatitis (HP:0006572) | 1.96229353 |
| 89 | Peripheral demyelination (HP:0011096) | 1.95401565 |
| 90 | Mitral valve prolapse (HP:0001634) | 1.93813109 |
| 91 | Abnormality of oral frenula (HP:0000190) | 1.93313709 |
| 92 | Thin bony cortex (HP:0002753) | 1.92990338 |
| 93 | Abnormality of the acetabulum (HP:0003170) | 1.92813498 |
| 94 | Hypophosphatemic rickets (HP:0004912) | 1.92780112 |
| 95 | Increased circulating renin level (HP:0000848) | 1.92349412 |
| 96 | Hyperextensible skin (HP:0000974) | 1.91022238 |
| 97 | Focal segmental glomerulosclerosis (HP:0000097) | 1.90858068 |
| 98 | Arterial tortuosity (HP:0005116) | 1.90309302 |
| 99 | Spinal rigidity (HP:0003306) | 1.89023172 |
| 100 | Retinal atrophy (HP:0001105) | 1.88610912 |
| 101 | Cerebral aneurysm (HP:0004944) | 1.88052773 |
| 102 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.87316066 |
| 103 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.87316066 |
| 104 | Esophageal varix (HP:0002040) | 1.86232099 |
| 105 | Bladder diverticulum (HP:0000015) | 1.86113019 |
| 106 | Aortic dissection (HP:0002647) | 1.84754247 |
| 107 | Orthostatic hypotension (HP:0001278) | 1.84124757 |
| 108 | Hyperglycemia (HP:0003074) | 1.83757078 |
| 109 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.83703340 |
| 110 | Microglossia (HP:0000171) | 1.83518113 |
| 111 | Hemorrhage of the eye (HP:0011885) | 1.83445881 |
| 112 | Overgrowth (HP:0001548) | 1.83344040 |
| 113 | Glomerulosclerosis (HP:0000096) | 1.82707368 |
| 114 | Glomerulonephritis (HP:0000099) | 1.82501396 |
| 115 | Vacuolated lymphocytes (HP:0001922) | 1.81563092 |
| 116 | Mitral stenosis (HP:0001718) | 1.80678351 |
| 117 | Syringomyelia (HP:0003396) | 1.80614040 |
| 118 | Spinal cord lesions (HP:0100561) | 1.80614040 |
| 119 | Steatorrhea (HP:0002570) | 1.80345134 |
| 120 | Amyloidosis (HP:0011034) | 1.80015329 |
| 121 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.79346522 |
| 122 | Dilatation of the ascending aorta (HP:0005111) | 1.79204008 |
| 123 | Absent frontal sinuses (HP:0002688) | 1.78956027 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 1.78467545 |
| 125 | Hydroxyprolinuria (HP:0003080) | 1.78467545 |
| 126 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78159308 |
| 127 | Blue sclerae (HP:0000592) | 1.78016676 |
| 128 | Abnormality of purine metabolism (HP:0004352) | 1.77589529 |
| 129 | Vascular tortuosity (HP:0004948) | 1.77582620 |
| 130 | Hypokalemic alkalosis (HP:0001949) | 1.77162571 |
| 131 | Visceral angiomatosis (HP:0100761) | 1.76983014 |
| 132 | Cardiovascular calcification (HP:0011915) | 1.75450469 |
| 133 | Abnormality of the lumbar spine (HP:0100712) | 1.73433880 |
| 134 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73300698 |
| 135 | Shallow orbits (HP:0000586) | 1.73210087 |
| 136 | Abnormality of methionine metabolism (HP:0010901) | 1.72957111 |
| 137 | Relative macrocephaly (HP:0004482) | 1.72775756 |
| 138 | Hypercholesterolemia (HP:0003124) | 1.71952798 |
| 139 | Congenital glaucoma (HP:0001087) | 1.71514331 |
| 140 | Broad metatarsal (HP:0001783) | 1.70697151 |
| 141 | Femoral bowing (HP:0002980) | 1.70278033 |
| 142 | Axonal loss (HP:0003447) | 1.69514987 |
| 143 | Advanced eruption of teeth (HP:0006288) | 1.68873611 |
| 144 | Spondylolisthesis (HP:0003302) | 1.68867574 |
| 145 | Natal tooth (HP:0000695) | 1.68462397 |
| 146 | Abnormal foot bone ossification (HP:0010675) | 1.66540801 |
| 147 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.64960794 |
| 148 | Long toe (HP:0010511) | 1.64563968 |
| 149 | Breech presentation (HP:0001623) | 1.64266014 |
| 150 | Abnormal ossification of hand bones (HP:0005921) | 1.63393331 |
| 151 | Osteopenia (HP:0000938) | 1.62807390 |
| 152 | Proximal tubulopathy (HP:0000114) | 1.60810463 |
| 153 | Ovoid vertebral bodies (HP:0003300) | 1.60539760 |
| 154 | Pulmonic stenosis (HP:0001642) | 1.60374309 |
| 155 | Limb-girdle muscle atrophy (HP:0003797) | 1.60035385 |
| 156 | Limb-girdle muscle weakness (HP:0003325) | 1.59291863 |
| 157 | Chondrocalcinosis (HP:0000934) | 1.58609565 |
| 158 | Periodontitis (HP:0000704) | 1.58597944 |
| 159 | Aneurysm (HP:0002617) | 1.57603442 |
| 160 | Elbow flexion contracture (HP:0002987) | 1.57106187 |
| 161 | Knee flexion contracture (HP:0006380) | 1.55630055 |
| 162 | Wrist flexion contracture (HP:0001239) | 1.55071089 |
| 163 | Glucose intolerance (HP:0000833) | 1.54790838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.03724567 |
| 2 | FRK | 2.95041186 |
| 3 | PKN2 | 2.93692672 |
| 4 | TRIB3 | 2.75403125 |
| 5 | FGFR2 | 2.64432121 |
| 6 | EPHB1 | 2.62314572 |
| 7 | MAP3K2 | 2.54857029 |
| 8 | ERBB3 | 2.50225386 |
| 9 | SCYL2 | 2.48478264 |
| 10 | INSRR | 2.39471158 |
| 11 | TAOK3 | 2.37830718 |
| 12 | PTK6 | 2.33904779 |
| 13 | MET | 2.25358715 |
| 14 | EIF2AK3 | 2.19243196 |
| 15 | LATS1 | 2.10507146 |
| 16 | LATS2 | 2.08821987 |
| 17 | EPHA2 | 2.01847917 |
| 18 | OXSR1 | 1.90260267 |
| 19 | RIPK1 | 1.84405370 |
| 20 | WNK4 | 1.82399394 |
| 21 | SIK1 | 1.81954031 |
| 22 | PDGFRA | 1.81793847 |
| 23 | PAK4 | 1.80159603 |
| 24 | EIF2AK1 | 1.78484447 |
| 25 | DDR2 | 1.73896152 |
| 26 | MAP3K6 | 1.70591650 |
| 27 | ERN1 | 1.67436894 |
| 28 | STK38L | 1.67380222 |
| 29 | LMTK2 | 1.59566108 |
| 30 | MYLK | 1.57892502 |
| 31 | MST1R | 1.53188306 |
| 32 | TSSK6 | 1.50039025 |
| 33 | TESK1 | 1.43126114 |
| 34 | NEK1 | 1.40992775 |
| 35 | NTRK1 | 1.40791199 |
| 36 | AKT3 | 1.35506736 |
| 37 | CAMK1D | 1.33718909 |
| 38 | RET | 1.26657913 |
| 39 | ERBB4 | 1.24736372 |
| 40 | MAP3K12 | 1.23587960 |
| 41 | PAK3 | 1.20506413 |
| 42 | BRSK2 | 1.20287193 |
| 43 | CAMK1G | 1.19815937 |
| 44 | FGFR4 | 1.19364135 |
| 45 | PDGFRB | 1.19109398 |
| 46 | PTK2 | 1.18637982 |
| 47 | BMPR2 | 1.18047512 |
| 48 | MAPK15 | 1.15427237 |
| 49 | JAK1 | 1.14696440 |
| 50 | TRIM28 | 1.14365900 |
| 51 | KSR2 | 1.12459819 |
| 52 | YES1 | 1.11215698 |
| 53 | TTN | 1.09047158 |
| 54 | STK24 | 1.08527183 |
| 55 | TGFBR2 | 1.07263756 |
| 56 | CSNK1A1L | 1.06235242 |
| 57 | WNK1 | 1.05589747 |
| 58 | HIPK2 | 1.04324783 |
| 59 | TTK | 1.03797628 |
| 60 | MST4 | 1.02584737 |
| 61 | TAF1 | 1.02359157 |
| 62 | EPHA3 | 1.02282570 |
| 63 | FLT3 | 1.01179681 |
| 64 | LRRK2 | 1.00559082 |
| 65 | PLK2 | 0.98618923 |
| 66 | GSK3A | 0.96219720 |
| 67 | IRAK3 | 0.95276364 |
| 68 | PBK | 0.94910747 |
| 69 | PKN1 | 0.92751510 |
| 70 | JAK2 | 0.92540798 |
| 71 | FGR | 0.91022964 |
| 72 | KSR1 | 0.90448739 |
| 73 | PAK2 | 0.89798089 |
| 74 | PDPK1 | 0.89749931 |
| 75 | BMX | 0.88620601 |
| 76 | NEK9 | 0.87776210 |
| 77 | TRPM7 | 0.86241991 |
| 78 | BCR | 0.86017329 |
| 79 | BRD4 | 0.83901108 |
| 80 | FGFR1 | 0.82497719 |
| 81 | STK38 | 0.82001077 |
| 82 | EPHB2 | 0.81159431 |
| 83 | CSK | 0.80396170 |
| 84 | DYRK1B | 0.79238679 |
| 85 | PRKCH | 0.78503555 |
| 86 | MAP3K3 | 0.78356288 |
| 87 | FER | 0.77441486 |
| 88 | CAMKK1 | 0.76456859 |
| 89 | MOS | 0.75792912 |
| 90 | MAP3K1 | 0.73012629 |
| 91 | CDK6 | 0.72595824 |
| 92 | STK3 | 0.72419463 |
| 93 | PDK1 | 0.72327773 |
| 94 | PRKD1 | 0.71853106 |
| 95 | PRKG2 | 0.70978374 |
| 96 | CSNK1G2 | 0.69680707 |
| 97 | LIMK1 | 0.68946763 |
| 98 | MAP3K9 | 0.66688797 |
| 99 | FGFR3 | 0.66453793 |
| 100 | PLK3 | 0.66077580 |
| 101 | CAMKK2 | 0.63719265 |
| 102 | ICK | 0.63223971 |
| 103 | INSR | 0.62631292 |
| 104 | TYK2 | 0.62264671 |
| 105 | PRKCQ | 0.62169695 |
| 106 | EGFR | 0.61776825 |
| 107 | ITK | 0.61691486 |
| 108 | NUAK1 | 0.60643201 |
| 109 | MAPKAPK5 | 0.57850449 |
| 110 | CSNK1G1 | 0.56182200 |
| 111 | DMPK | 0.56027541 |
| 112 | RPS6KA4 | 0.55545110 |
| 113 | TYRO3 | 0.54956585 |
| 114 | IGF1R | 0.54274088 |
| 115 | SRPK1 | 0.53853175 |
| 116 | NEK6 | 0.53511416 |
| 117 | PRKCE | 0.52271342 |
| 118 | FYN | 0.52267897 |
| 119 | PASK | 0.52213956 |
| 120 | WNK3 | 0.50280658 |
| 121 | PIK3CA | 0.50188104 |
| 122 | ERBB2 | 0.47222043 |
| 123 | CSNK1G3 | 0.46564502 |
| 124 | STK10 | 0.46222927 |
| 125 | MAP3K5 | 0.45955599 |
| 126 | CAMK2B | 0.44772635 |
| 127 | CSF1R | 0.43963821 |
| 128 | MELK | 0.42450989 |
| 129 | JAK3 | 0.42428941 |
| 130 | ABL1 | 0.42350155 |
| 131 | AKT2 | 0.42117288 |
| 132 | SRC | 0.42100791 |
| 133 | EEF2K | 0.41827312 |
| 134 | EIF2AK2 | 0.41155753 |
| 135 | ROCK2 | 0.40580414 |
| 136 | CASK | 0.39615350 |
| 137 | TBK1 | 0.38568653 |
| 138 | MAP2K2 | 0.38478706 |
| 139 | CAMK2D | 0.38156784 |
| 140 | ROCK1 | 0.33000598 |
| 141 | MAP3K8 | 0.32624725 |
| 142 | ARAF | 0.32608661 |
| 143 | PIK3CG | 0.28906678 |
| 144 | MAP3K4 | 0.27335970 |
| 145 | DYRK3 | 0.26210517 |
| 146 | CAMK2G | 0.25527605 |
| 147 | RAF1 | 0.24741937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.83981224 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.77905422 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.50969265 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.46484918 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.40008390 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.91529976 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.88648548 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.79472350 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77917550 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77674840 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69390998 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.67428275 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.63567688 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.59886024 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54630244 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.54499875 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.49051660 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46877096 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42912411 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.32222127 |
| 21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.31326254 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30456340 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.27709565 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27483134 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26888165 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26312885 |
| 27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.24438984 |
| 28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21263587 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20133115 |
| 30 | Thyroid cancer_Homo sapiens_hsa05216 | 1.18228779 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16863106 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.13858646 |
| 33 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13436754 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.12857315 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12609531 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.12575454 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10705173 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10224481 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08644305 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08190917 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.06607613 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06049873 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03686289 |
| 44 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.02415249 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01009674 |
| 46 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.99240930 |
| 47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97868324 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97555756 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96213466 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95738840 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94369626 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92145249 |
| 53 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.90237249 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.89787314 |
| 55 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89465582 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89013554 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88536977 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87932474 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87576440 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87485058 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.86359264 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85609347 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83962961 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81439728 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78325875 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76515352 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 0.76274660 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75679118 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75103955 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73826605 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73549285 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72348158 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72151123 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.71895647 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70827561 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.70367918 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68917448 |
| 78 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.68508667 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67973085 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.66330380 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64497808 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64261677 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63007238 |
| 84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62666503 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61582297 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.61400315 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61150750 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60310196 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60073480 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57533522 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57446095 |
| 92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56185096 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56129252 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56067055 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54894811 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.54726886 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54027459 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53286054 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52931932 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52225281 |
| 101 | Protein export_Homo sapiens_hsa03060 | 0.52065535 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51986392 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51567632 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.51238999 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50195132 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48572552 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48364829 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47782079 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47725849 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44160766 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42769710 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.42288063 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42004528 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.41663146 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.40903918 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.39601600 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38390645 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38206840 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.37563862 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37420861 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37348063 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37300485 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.37223344 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.34937943 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34167225 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.34005830 |
| 127 | Insulin secretion_Homo sapiens_hsa04911 | 0.33387535 |
| 128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33244098 |
| 129 | Axon guidance_Homo sapiens_hsa04360 | 0.33180147 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.33004445 |
| 131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32570309 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31862850 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.31684814 |
| 134 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31675040 |
| 135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30682226 |
| 136 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30399952 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30050309 |

